Project Grant R43DA056161
Award Date
7/1/22
Completion Date
4/30/23
Dollars Obligated
$512K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
North Carolina, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded a $800,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Tenvos Inc., a minority-owned and woman-owned technology company. The grant will support the development of a software-based medical device (SAMD) integrated into a smartphone application that can detect opioid use through voice analysis. The proposed solution aims to enable patients in outpatient opioid use disorder (OUD) treatment to remotely test for...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $239,148 to develop and pilot a telehealth program integrated with syringe service programs (SSPs) to improve uptake and retention of pre-exposure prophylaxis (PrEP) and medication for opioid use disorder (MOUD) among people who inject drugs (PWID). The three-year project, which runs from September 15, 2024 to July 31, 2027, aims to address key...
This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) provides $355,414 to Yale University to implement and evaluate a digital therapeutic for addressing substance use disorders (SUDs), including opioid use disorder (OUD), among incarcerated individuals. The key objectives are to: Assess attitudes and perceptions of using a digital therapeutic for SUDs, as well as barriers and facilitators to implementing the...
The National Institute on Drug Abuse (NIDA) awarded Evidation Health, Inc. a $304,023 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop RESHAPE, a digital platform addressing health-related social needs for individuals with substance use disorders (SUD). The goal of the project is to create a comprehensive digital experience that supports SUD recovery by providing personalized education, insights, and support. The RESHAPE platform will leverage...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $400,000 Fast-Track Small Business Innovation Research (SBIR) grant to Mountainpass Technology LLC. The purpose of this 2-year project grant is to develop, refine, and evaluate a customized version of the "MyTrials" integrated remote biomarker capture platform to support the unique needs of decentralized clinical trials for substance use disorders (SUDs). The key...
This $1,272,788.38 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will establish the PRIDE-CARES Center to address gaps in substance use disorder (SUD) research and treatment for the sexual and gender minority (SGM) community. The key products and services to be delivered include: Developing a Virtual Patient Engagement Panel (VIP Panel) to actively engage patients, family members, and individuals in...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to address racial disparities in opioid overdose deaths. The $451,962 grant, awarded on July 1, 2024, supports the development and evaluation of a multimodal intervention consisting of an AI-driven texting tool and peer recovery coach (PRC) telephone-based services coordination for Black and Latinx people who use opioids. The key products and services to...
The Project Grant award of $300,000.00 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program will fund the TEACH-SUD curriculum development at the University of California, San Francisco (UCSF). The TEACH-SUD program aims to train over 1,500 medical students, nurse practitioners, and pharmacists over 3 years to provide compassionate, evidence-based,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $591,752 to Oprems LLC to develop and evaluate a digital platform for screening patients who receive prescribed opioid medications for potential risk of opioid misuse and overdose. The key products and services to be delivered under this grant include integrating the screening tools and process developed by Oprems' existing...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is for $210,600 over a 5-year period from July 1, 2024 to June 30, 2029. The award will support Dr. Michael Incze, a general internist and addiction medicine physician, to design, refine, and pilot test an interdisciplinary "Addiction Care Transition (INTACT) Team" intervention. This intervention aims to improve transitions to primary...